Nigeria and the quest for a global antimicrobial resistance surveillance system, ca. 1980s - present
Examining Nigeria's efforts to develop a national anti-microbial resistance surveillance system.
The control of Antimicrobial Resistance (AMR) is a key goal of global health policy, but how does it play out at country level? Since the 1980s the World Health Organisation (WHO) has promoted AMR surveillance programmes, including the Gonococcal Antimicrobial Surveillance Programme (GASP), the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), the Global Antimicrobial Resistance Surveillance System (GLASS), and a couple of very specific and regional initiatives. Their primary objective is to drive the control of AMR using real-time empirical data collected across various locations that captures peculiar characteristics of patients, microbes and antimicrobials. The major problem of such programmes is in collecting sufficient data on antimicrobial consumption and use.
The focus of this study is one such programme, in Nigeria. It examines efforts by key institutions within the Nigerian health system to develop a coordinated and national AMR surveillance system since the 1980s. Unlike most other settings we know about, Nigeria lacks a national system for AMR surveillance. However this does not mean that policies and conversations around the topic are new to major stakeholders, within tertiary hospitals and health agencies, and outside the country. The presentation will reveal the specific challenges and prospects key actors have encountered in the course of negotiating and implementing campaigns and interventions on national surveillance initiatives.
It should interest staff, students and others with interests in the recent history of AMR, and in global health programmes which seek to control it.
Speaker
Adedamola Adetiba, CHSTM, University of Manchester
Event notices
- Please note that the recording link will be listed on this page when available.
Admission
Contact